Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-α) receptors in type C chronic liver disease

Clinical and Experimental Immunology

Volumn 109, Issue 3, 1997, Pages 458-463

  Kakumu, S ^a   Okumura, A ^a   Ishikawa, T ^a   Yano, M ^b   Enomoto, A ^b   Nishimura, H ^b   Yoshioka, K ^b   Yoshikai, Y ^b  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IL 10; IL 15; Serum level; TNF receptor; Type C liver disease

Indexed keywords

AMINOTRANSFERASE; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC LIVER DISEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE ACTIVATION;

EID: 0030770259     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4861382.x     Document Type: Article

References (26)

1. Kuo G, Choo Q-L, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244:362-4.
2. Houghton M, Weiner AJ, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14:381-8.
3. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671-5.
4. Weiner AJ, Geysen HM, Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89:3468-72.
5. Koziel MJ, Dudley D, Wong JT et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149:3339-44.
6. Iwata K, Wakita T, Okumura A et al. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 1995; 22:1057-64.
7. Beutler B. Tumor necrosis factors: the molecules and their emerging role in medicine. New York: Raven Press, 1992.
8. Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumor necrosis factor a production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989; 10:769-73.
9. Yoshioka K, Kakumu S, Arao M et al. Immunohistochemical studies of intrahepatic tumor necrosis factor α in chronic liver disease. J Clin Pathol 1990;43:298-302.
10. Beutler B, van Huffel C. Unraveling function in the TNF ligand and receptor families. Science 1994; 264:667-8.
11. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann T. Interleukin 10. Annu Rev Immunol 1994; 11:165-90.
12. Kuzushita N, Hayashi N, Katayama K et al. Elevated serum levels of IL-10 in patients with acute and chronic HCV carriers. Hepatolgy 1995; 22:356A.
13. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and posttreatment with interferon alfa. Hepatology 1996; 24:6-9.
14. Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994; 365:965-7.
15. Nishimura H, Hiromatsu K, Kobayashi N et al. IL-15 is a novel growth factor for murine γδ T cells induced by Salmonella infection. J Immunol 1996; 156:663-9.
16. McInnes IB, Al-Mughales J, Field M et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nature Med 1996; 2:175-82.
17. Yoshioka K, Kakumu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16:293-9.
18. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513-20.
19. Lau JYN, Davis GL, Kniffen J et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341:1501-4.
20. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory. Eur J Haematol 1995; 54:1-8.
21. Bilello JA, Stellrecht K, Drusano GL, Stein DS. Soluble tumor necrosis factor-α receptor type II (sTNFαRII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J Infect Dis 1996; 173:464-7.
22. Salles G, Bienvenu J, Bastion Y et al. Elevated circulating levels of TNFα and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Brit J Hematol 1996; 93:352-9.
23. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4 have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994; 24:2699-705.
24. Leeuwenberg JF, Jeunhomme TM, Buurman WA. Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 1994; 152:4036-43.
25. Carson WE, Giri JG, Lindemann MJ et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180:1395-403.
26. Aderka D, Engelmann H, Hornik V et al. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 1991; 51:5602-7.